| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203079A2 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 05/08/2002 | EP1203076A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 05/08/2002 | EP1203075A1 Cell culture systems and methods for organ assist devices |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203022A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
| 05/08/2002 | EP1203016A2 Proteases and protease inhibitors |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203013A1 Kinase blocking polypeptides and uses thereof |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1092021A4 Npy-y7 receptor gene |
| 05/08/2002 | EP1034309B1 Method for producing complex dna methylation fingerprints |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0915648B1 Methods and compositions for the selective modification of nucleic acids |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348467A Antibodies to placental protein 13 |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1348332A Vaccines and gene therapy compositions and methods of making and using the same |
| 05/08/2002 | CN1348005A Prepn and use of reconstituted target cysteine asparagusic enzyme gene |
| 05/08/2002 | CN1348000A Alpha-amylase with high production capacity |
| 05/08/2002 | CN1347984A Culture and production of in vitro plant cell with chitosan to replace exogenous plant hormone |
| 05/08/2002 | CN1347983A Low temperature preserving agent for preserving umbilical blood hemopoietic stem cell |
| 05/07/2002 | US6384301 Rapid and efficient process which does not involve a callus-phase tissue culture |
| 05/07/2002 | US6384300 Invertase inhibitor |
| 05/07/2002 | US6384299 Plant retinoblastoma-associated gene |
| 05/07/2002 | US6384207 Regulatory sequences for transgenic plants |
| 05/07/2002 | US6384203 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 05/07/2002 | US6384192 Amino acid sequence of hedgehog proteins which binds to patched receptor |
| 05/07/2002 | US6384191 Receptors for fibroblast growth factors |
| 05/07/2002 | US6384190 Peptide of defined amino acid sequence which binds to human leukocyte antigen-a2 |
| 05/07/2002 | US6384189 Compositions for stimulating TGF-β activity |
| 05/07/2002 | US6384105 Injectable, in situ crosslinkable, biodegradable carrier for bioactive drug delivery |
| 05/07/2002 | US6384012 Use of isolated domains of type IV collagen to modify cell and tissue interactions |
| 05/07/2002 | US6383810 Rapidly dissolving nutritionally complex stable dry powder which can be prepared in variable bulk quantities and can be sterilized by ionizing or ultraviolet irradiation; agglomerating a dry powder nutritive media with a solvent |
| 05/07/2002 | US6383807 Method of transforming T lymphocytes |
| 05/07/2002 | US6383806 Method for the development of an HIV vaccine |
| 05/07/2002 | US6383805 Epithelial cell cultures for in vitro testing |
| 05/07/2002 | US6383794 Methods of producing high titer recombinant adeno-associated virus |
| 05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
| 05/07/2002 | US6383790 Pyrazolo(3,4-d)pyrimidine based compound; anticarcinogenic agents; antitumor agents |
| 05/07/2002 | US6383786 Method for producing α-hydroxy acid from α-hydroxy nitrile using nitrilase |
| 05/07/2002 | US6383785 Self-enhancing, pharmacologically controllable expression systems |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383778 Nucleotide sequence which codes for receptor that binds to phenylthiocarbamide ligand; for taste modulating compounds for use in food and drug industries |
| 05/07/2002 | US6383765 Polypeptides of feline T-cell lymphotropic lentivirus |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383732 Method of preparing xenograft heart valves |
| 05/07/2002 | US6383487 Antitumor |
| 05/07/2002 | US6383486 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/07/2002 | US6383480 Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells |
| 05/07/2002 | US6383478 Polymeric encapsulation system promoting angiogenesis |
| 05/07/2002 | US6383029 Method of reducing signal coupling in a connector, a connector and a cable including such a connector |
| 05/07/2002 | CA2214503C Method for treating tumors |
| 05/07/2002 | CA1341357C Platelet-specific chimeric immunoglobulin |
| 05/03/2002 | CA2360907A1 Production of interesting metabolites by co-culture of plant and non-plant cells |
| 05/02/2002 | WO2002034945A2 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
| 05/02/2002 | WO2002034923A2 Monocotyledon plant cells and plants which synthesise modified starch |
| 05/02/2002 | WO2002034922A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/02/2002 | WO2002034919A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 05/02/2002 | WO2002034914A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | WO2002034909A2 Engineered chimera of hiv protein fragments and uses thereof |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034899A2 Tec kinase assay |
| 05/02/2002 | WO2002034895A2 Novel aggrecanase molecules |
| 05/02/2002 | WO2002034891A2 Immortalized preosteoblasts and method for their production |
| 05/02/2002 | WO2002034890A2 Pluripotential stem cells |
| 05/02/2002 | WO2002034889A2 Therapeutic uses for mesenchymal stromal cells |
| 05/02/2002 | WO2002034888A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 05/02/2002 | WO2002034887A2 Maturation of dendritic cells |
| 05/02/2002 | WO2002034885A1 Sericin-containing material, process for producing the same and method of using the same |
| 05/02/2002 | WO2002034879A2 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 05/02/2002 | WO2002034789A1 Monoclonal antibodies directed against hepatitis b viruses |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034306A1 Surface modification of islet membranes by polymeric grafting methods |
| 05/02/2002 | WO2002034288A2 Vaccine for treating allergy |
| 05/02/2002 | WO2002034272A2 Methods of improving central nervous system functioning |
| 05/02/2002 | WO2002034041A1 Senescence marker protein 30-defective nonhuman animal, antibody and method of constructing the same |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2002019812A3 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 05/02/2002 | WO2002012537A3 Mutant trichosanthin |
| 05/02/2002 | WO2002010344A3 Synchronised arabidopsis cell suspensions and uses thereof |
| 05/02/2002 | WO2002008388A3 Stem cell-like cells |
| 05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |
| 05/02/2002 | WO2002004523A3 Artificial antibody polypeptides |
| 05/02/2002 | WO2001098361A3 Agonist anti-trk-c monoclonal antibodies |
| 05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
| 05/02/2002 | WO2001090147A3 Long wavelength engineered fluorescent proteins |
| 05/02/2002 | WO2001087932A3 Seven transmembrane proteins and polynucleotides encoding the same |
| 05/02/2002 | WO2001085787A3 Stable rxr expressing cell line |